Browsing Category
Health
Gracell Biotechnologies to Participate in Two Upcoming Virtual Investor Conferences
SUZHOU, China and PALO ALTO, Calif., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious…
Sensus Healthcare to Participate in Fireside Chat Hosted by Maxim Group and M-Vest
BOCA RATON, Fla, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and…
Albireo to Showcase New Data at AASLD The Liver Meeting® 2021
– Seven abstracts accepted highlighting data in pediatric cholestatic and viral liver diseases – – Phase 3 Bylvay™ (odevixibat) data presentations on long-term treatment benefits show evidence of improved liver health and function across…
Celsion Corporation Announces Time of Oral Presentation at International Vaccines Congress
Chief Science Officer Dr. Khursheed Anwer to Deliver Virtual Presentation Monday, October 18 at 7:30 a.m. Eastern Time LAWRENCEVILLE, N.J., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage…
IDFC FIRST Bank and Banyan Academy of Leadership in Mental Health Launch The Centre for Trauma…
NewsVoir
27
IDFC FIRST Bank today announced the launch of India’s first Centre for Trauma Studies and Innovation (CTSI), in association with Banyan Academy of Leadership in Mental Health (BALM). The initiative, that was launched on World Mental…
Sienna Announces October Dividend
MARKHAM, Ontario, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “Common Share”) for the month of October…
Unaware of Any Undisclosed Material Change
TORONTO, Oct. 15, 2021 (GLOBE NEWSWIRE) -- At the request of the Investment Industry Regulatory Organization of Canada (IIROC), Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) wishes to confirm that…
US FDA approves Roche’s Tecentriq as adjuvant treatment for certain people with early non-small cell…
Tecentriq is the first and only cancer immunotherapy approved for NSCLC in the adjuvant settingApproval is based on the Phase III IMpower010 study showing adjuvant Tecentriq improved disease-free survival by more than one-third in…
Disclosure of received notification of The Capital Group Companies and NN Group NV
GlobeNewswire
107
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 15 October 2021 Disclosure of received notification of The Capital Group Companies and NN Group NV Pursuant to the Belgian law of 2 May 2007 regarding…
Chinook Therapeutics Announces Upcoming Data Presentations and Investor Conference Call During the…
Additional data to be presented from the ongoing phase 1/2 study of BION-1301 in patients with IgA nephropathy, including biomarker and proteinuria reductions Several presentations on the atrasentan clinical program, including…
Cabaletta Bio Announces Presentation of Preclinical Data Supporting PLA2R-CAART as a Potential…
– Chimeric AutoAntibody Receptor (CAAR) T cells specifically recognized and eliminated anti-PLA2R antibody-expressing B cells in vitro – – Membrane proteome arrays screened with PLA2R CAAR candidates did not identify off-target…